A. M. Rueda

发表

Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus

D. Musher, S. Shelburne, K. Hulten, 2006 .

Nontypeable Haemophilus influenzae as a Cause of Spontaneous Bacterial Peritonitis

D. Musher, A. Rueda, A. Nichol, 2006, Journal of Clinical Microbiology.

Long-term survival following pneumococcal pneumonia.

D. Musher, A. Rueda, Barcleigh P Sandvall, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.

D. Musher, S. Shelburne, K. Hulten, 2006, The Journal of antimicrobial chemotherapy.

The incidence of necrotizing changes in adults with pneumococcal pneumonia.

D. Musher, Anupam Pande, Rebecca Matejowsky, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Community-Associated Strains of Methicillin-Resistant Staphylococccus aureus as the Cause of Healthcare-Associated Infection

D. Musher, S. Shelburne, K. Hulten, 2006, Infection Control & Hospital Epidemiology.

White Blood Cell Counts, Alcoholism, and Cirrhosis in Pneumococcal Pneumonia

D. Musher, E. Graviss, D. Nguyen, 2017, Open forum infectious diseases.

Hyperglycemia in diabetics and non-diabetics: effect on the risk for and severity of pneumococcal pneumonia.

D. Musher, T. Giordano, Meghana Gore, 2010, The Journal of infection.

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults

D. Musher, J. Raab, A. Rueda, 2011, Human vaccines.

The Impact of Statin and Macrolide Use on Early Survival in Patients With Pneumococcal Pneumonia

D. Musher, J. Liao, A. Rueda, 2013, The American journal of the medical sciences.

Detection of Listeria monocytogenes in raw whole milk for human consumption in Colombia by real-time PCR

Aída Juliana Martínez, María Consuelo Vanegas, A. M. Rueda, 2009 .

Acute Bacterial Pneumonia is Associated With the Occurrence of Acute Coronary Syndromes

D. Musher, B. Bozkurt, D. Tweardy, 2008, Medicine.

The association between pneumococcal pneumonia and acute cardiac events.

D. Musher, A. Kaka, A. M. Rueda, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The obesity paradox in community-acquired bacterial pneumonia.

D. Musher, V. Corrales-Medina, J. Serpa, 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial.

L. Pirofski, M. Rodriguez‐Barradas, J. Serpa, 2015, The Journal of infectious diseases.

Anemia and community-acquired pneumococcal pneumonia

D. Musher, V. Corrales-Medina, A. Rueda, 2011, Infection.

The Spectrum of Invasive Pneumococcal Disease at an Adult Tertiary Care Hospital in the Early 21st Century

D. Musher, J. Serpa, A. Rueda, 2010, Medicine.

Predicting Lymph Node Metastasis in Non-Small Cell Lung Cancer: Prospective External and Temporal Validation of the HAL and HOMER Models.

L. Yarmus, D. Feller-Kopman, S. Murgu, 2021, Chest.

Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection

A. Somasunderam, M. Rodriguez‐Barradas, J. Couturier, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.

D. Musher, E. Graviss, M. Nahm, 2008, The Journal of infectious diseases.

Response to Pneumococcal Polysaccharide and Protein-Conjugate Vaccines Singly or Sequentially in Adults who have Recovered from Pneumococcal Pneumonia

D. Musher, M. Nahm, M. Rodriguez‐Barradas, 2009 .

Multiple‐dose granulocyte‐macrophage–colony‐stimulating factor plus 23‐valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia

D. Musher, M. Keating, S. O'brien, 2008, Cancer.

Acute Onset of Pneumococcal Pneumonia Following Instrumentation of the Respiratory Tract

D. Musher, A. Rueda, J. G. Gardner, 2018, Open forum infectious diseases.

Antibody persistence 10 years after 1st and 2nd doses of 23-valent pneumococcal polysaccharide vaccine (PN23), and immunogenicity and safety of 2nd and 3rd doses in older adults

D. Musher, C. Liss, S. Manoff, 2010 .

L. Pirofski, M. Rodriguez‐Barradas, J. Serpa, 2015, The Journal of infectious diseases.